It has been confirmed that GPC-3 can be used to detect AFP-negative HCC cases, and GPC-3 mRNA is remarkably upregulated in HCC compared to normal and benign liver samples (52, 53). The gene discussed is GPC3; the disease is hepatocellular carcinoma.